Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agilent Technologies Inc (NYSE:A)

72.06
Delayed Data
As of Jan 17
 +0.83 / +1.17%
Today’s Change
47.05
Today|||52-Week Range
72.47
+7.60%
Year-to-Date
7 Investment Themes You Can't Afford to Miss for 2018
Jan 16 / TheStreet.com - Paid Partner Content
Agilent (A) Expands Portfolio With Luxcel Biosciences Buyout
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close71.23
Today’s open71.72
Day’s range71.59 - 72.31
Volume1,824,511
Average volume (3 months)1,701,687
Market cap$22.9B
Data as of 4:01pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+9.38%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+6.43%
P/E ratio34.3
Price/Sales4.96
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
MTDMettler-Toledo Inter...+7.09+1.09%
WATWaters Corp+0.22+0.11%
QGENQiagen NV+0.28+0.86%
PKIPerkinElmer Inc+1.12+1.43%
Data as of 4:03pm ET, 01/17/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.58
Annual revenue (last year)$4.5B
Annual profit (last year)$684.0M
Net profit margin15.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael R. McMullen
Vice President-Operations, Quality &
Support
Kristin Giffin
Corporate headquarters
Santa Clara, California

Forecasts